Oscar Health (NYSE:OSCR) Insider Adam Mcananey Sells 9,092 Shares

Oscar Health, Inc. (NYSE:OSCR) insider Adam Mcananey sold 9,092 shares of the business’s stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $285,943.40. Following the transaction, the insider owned 209,004 shares in the company, valued at approximately $6,573,175.80. The trade was a 4.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Stock Up 2.0%

NYSE OSCR opened at $32.90 on Wednesday. Oscar Health, Inc. has a twelve month low of $10.69 and a twelve month high of $33.55. The stock has a market cap of $10.15 billion, a PE ratio of 23.50, a PEG ratio of 0.66 and a beta of 2.37. The firm has a 50-day simple moving average of $30.58 and a 200 day simple moving average of $23.01. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Thursday, August 6th. The company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The company had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.73 billion. During the same quarter last year, the company earned ($0.89) EPS. The company’s quarterly revenue was up 70.4% on a year-over-year basis. On average, research analysts forecast that Oscar Health, Inc. will post 1.54 EPS for the current year.

Institutional Investors Weigh In On Oscar Health

A number of hedge funds and other institutional investors have recently made changes to their positions in OSCR. GAMMA Investing LLC increased its holdings in Oscar Health by 32.9% during the 2nd quarter. GAMMA Investing LLC now owns 1,441 shares of the company’s stock worth $41,000 after purchasing an additional 357 shares in the last quarter. Focus Partners Wealth lifted its holdings in shares of Oscar Health by 1.4% in the third quarter. Focus Partners Wealth now owns 57,787 shares of the company’s stock valued at $1,094,000 after purchasing an additional 824 shares in the last quarter. Equitable Holdings Inc. lifted its holdings in shares of Oscar Health by 7.0% in the fourth quarter. Equitable Holdings Inc. now owns 12,975 shares of the company’s stock valued at $186,000 after purchasing an additional 850 shares in the last quarter. IFP Advisors Inc boosted its position in shares of Oscar Health by 69.5% during the second quarter. IFP Advisors Inc now owns 2,139 shares of the company’s stock worth $61,000 after buying an additional 877 shares during the period. Finally, Captrust Financial Advisors grew its holdings in shares of Oscar Health by 2.0% during the fourth quarter. Captrust Financial Advisors now owns 45,754 shares of the company’s stock worth $657,000 after buying an additional 895 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. Zacks Research upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. Wells Fargo & Company upped their target price on shares of Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a research report on Thursday, August 13th. Piper Sandler reissued an “overweight” rating and issued a $36.00 price target on shares of Oscar Health in a research note on Tuesday, July 28th. The Goldman Sachs Group reissued a “neutral” rating and set a $30.00 price objective on shares of Oscar Health in a research note on Tuesday, August 11th. Finally, UBS Group boosted their price target on shares of Oscar Health from $20.00 to $26.00 and gave the company a “neutral” rating in a report on Friday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $26.22.

Key Stories Impacting Oscar Health

Here are the key news stories impacting Oscar Health this week:

• Neutral Sentiment: Director Mario Schlosser sold 31,422 shares for approximately $988,000 and retained 449,444 shares. Mario Schlosser SEC filing
• Neutral Sentiment: CFO Richard Blackley sold 28,869 shares valued at roughly $908,000, while continuing to own more than 1.04 million shares. Richard Blackley SEC filing
• Neutral Sentiment: Other insiders Adam Mcananey, Janet Liang and Chief Accounting Officer Victoria Baltrus sold approximately $642,000 combined. Each sale was also tied to tax obligations and represented only a modest reduction in their respective holdings. Adam Mcananey SEC filing Janet Liang SEC filing Victoria Baltrus SEC filing

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.